The Kidney Innovation Accelerator (KidneyX) is a public-private partnership between the US Department of Health and Human Services and the American Society of Nephrology to accelerate innovation in the prevention, diagnosis, and treatment of kidney diseases. KidneyX seeks to improve the lives of the 37 million Americans currently affected by kidney diseases by accelerating the development of drugs, devices, biologics, and other therapies across the spectrum of kidney care including prevention, diagnostics, and treatment.
Building off the success of similar public-private accelerators, KidneyX will engage a community of researchers, innovators, and investors to bring breakthrough therapies to patients through a series of prize competitions. Together—through KidneyX—we plan to accelerate the pace of innovation in the development of disruptive approaches to kidney care and the development of new medical products, leading to solutions that will improve the lives of the millions of people worldwide affected by kidney diseases. We hope you will consider joining us in this effort.
Artificial Kidney Prize Phase 2